Financials in USD. Standardized financial statements.
A compact view of how ISE Chemicals Corporation turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Revenue? | $39.29B | $33.29B | $26.41B | $25.56B | $20.35B | $16.86B | $16.85B |
| Revenue Growth? | +18.0% | +26.0% | +3.3% | +25.6% | +20.7% | +0.0% | 0.0% |
| Cost of Revenue? | $26.92B | $23.18B | $19.03B | $19.89B | $15.91B | $13.07B | $13.23B |
| Gross Profit? | $12.37B | $10.11B | $7.39B | $5.67B | $4.45B | $3.79B | $3.62B |
| Gross Margin? | +31.5% | +30.4% | +28.0% | +22.2% | +21.9% | +22.5% | +21.5% |
| Operating Expenses? | $2.88B | $2.45B | $2.09B | $1.92B | $1.74B | $1.60B | $1.56B |
| Operating Income? | $9.49B | $7.66B | $5.30B | $3.76B | $2.71B | $2.19B | $2.06B |
| EBITDA? | $11.54B | $9.39B | $7.17B | $5.57B | $4.20B | $3.50B | $3.17B |
| Income Before Tax | $9.16B | $7.41B | $5.20B | $3.60B | $2.59B | $1.99B | $1.81B |
| Income Tax Expense | $2.65B | $2.34B | $1.53B | $1.04B | $818.00M | $645.00M | $621.00M |
| Net Income? | $6.50B | $5.07B | $3.67B | $2.56B | $1.77B | $1.34B | $1.19B |
| EPS? | $127.05 | $99.52 | $72.05 | $50.27 | $34.79 | $0.26 | $0.23 |
| Diluted EPS? | $127.05 | $99.52 | $72.05 | $50.27 | $34.79 | $0.26 | $0.23 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality